Results 261 to 270 of about 757,323 (338)
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases
Arthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci +25 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 10, October 2026.ABSTRACT Background Merkel Cell Carcinoma (MCC) is a rare, aggressive neuroendocrine and epithelial skin cancer. Somatostatin analogues, such as lanreotide, have shown efficacy in managing other neuroendocrine tumors. Retrospective studies suggest that lanreotide may induce partial response or disease stabilization in patients with advanced MCC.
Julie Charles +23 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 10, October 2026.ABSTRACT Multiple public databases, including TCGA, GEO, and TARGET, were utilized to comprehensively analyze pyridoxal phosphatase (PDXP) expression profiles across 34 cancer types. We further explored the associations of PDXP expression with clinicopathological features, tumor immune microenvironment, genomic heterogeneity, functional signaling ...
Yingjian Hu +5 more
wiley +1 more source
The Impact of SF3B1 Mutations on the Tumor Microenvironment and Response to Immunotherapy
Cancer Medicine, Volume 15, Issue 10, October 2026.ABSTRACT Cancer genomes shape the immune landscape within the tumor microenvironment (TME), thereby influencing host antitumor immunity. Identifying somatic mutations that modulate the TME is critical for selecting patients most likely to benefit from immunotherapy.
Kyung‐Jin Cho, Byungho Lim
wiley +1 more source
Pigmented Poroid Hidradenoma: A Case Report
Clinical Case Reports, Volume 14, Issue 10, October 2026.ABSTRACT Poroid hidradenoma (PH) is an infrequently encountered benign adnexal neoplasm exhibiting eccrine differentiation. Histopathologically, PH displays a distinctive combination of hidradenoma‐like architectural organization characterized by a purely intradermal localization with both solid and cystic components, and cytological attributes of ...
Baraa Bustami +2 more
wiley +1 more source
Intranodal Epithelioid Schwannoma in an Intraparotid Lymph Node: A Case Report and Literature Review
Clinical Case Reports, Volume 14, Issue 10, October 2026.ABSTRACT An epithelioid schwannoma arising within an intraparotid lymph node is a rare benign lesion that may mimic metastatic melanoma, metastatic carcinoma, or a primary salivary gland neoplasm. Recognizing the intranodal architecture and integrating morphology with an appropriate immunohistochemical panel are essential to avoid misclassification and
Maryam Vajihinejad +3 more
wiley +1 more source
New Primary and Secondary Prevention Measures for Cutaneous Melanoma: A Systematic Review
Cancer Reports, Volume 9, Issue 10, October 2026.ABSTRACT Background Cutaneous melanoma is the deadliest type of skin cancer, with increasing incidence and mortality rates. Therefore, primary and secondary prevention are of utmost importance. Claims The objective is to evaluate new recent evidence on primary and secondary prevention strategies for cutaneous melanoma.
Maria Palau–del–Valle +2 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Seminars in Oncology Nursing, 1991
C UTANEOUS MALIGNANT melanoma (CMM) is a cancer that arises in the melanin-producing cells called melanocytes. It is one of the most easily detected cancers, as the patient usually presents with a skin lesion that is readily visible. Melanomas that are detected early are almost always curable by surgical excision.’ With this in mind, the importance of ...
C, Grin-Jorgenson, A W, Kopf, J C, Maize
openaire +4 more sources
C UTANEOUS MALIGNANT melanoma (CMM) is a cancer that arises in the melanin-producing cells called melanocytes. It is one of the most easily detected cancers, as the patient usually presents with a skin lesion that is readily visible. Melanomas that are detected early are almost always curable by surgical excision.’ With this in mind, the importance of ...
C, Grin-Jorgenson, A W, Kopf, J C, Maize
openaire +4 more sources
Journal of Cutaneous Medicine and Surgery, 2019
Background: We recently reported a steady increase in the incidence and mortality of cutaneous malignant melanoma (CMM) in Canada during 1992-2010. Objectives: The objective of this article is to examine the distribution of Canadian CMM patients at the ...
F. Ghazawi +12 more
semanticscholar +1 more source
Background: We recently reported a steady increase in the incidence and mortality of cutaneous malignant melanoma (CMM) in Canada during 1992-2010. Objectives: The objective of this article is to examine the distribution of Canadian CMM patients at the ...
F. Ghazawi +12 more
semanticscholar +1 more source